Table of Contents
When patients are prescribed SGLT2 inhibitors, such as canagliflozin or dapagliflozin, regular kidney function tests become essential. These medications, used primarily for managing type 2 diabetes, can impact kidney health, making monitoring crucial.
Why Kidney Monitoring Is Important
SGLT2 inhibitors work by helping the kidneys remove excess glucose from the bloodstream through urine. While effective, this process can sometimes affect kidney function, especially in patients with pre-existing kidney issues or other risk factors.
Recommended Tests and Frequency
- Serum Creatinine Test
- Estimated Glomerular Filtration Rate (eGFR)
- Urinalysis for Protein
These tests are typically recommended before starting SGLT2 inhibitors, then periodically during treatment. The frequency may vary depending on individual health status, but generally, testing every 3 to 6 months is advised.
Signs of Kidney Problems
Patients should be aware of symptoms indicating kidney issues, such as:
- Swelling in the legs or ankles
- Fatigue
- Changes in urination patterns
- Persistent nausea
If any of these symptoms occur, patients should consult their healthcare provider promptly for further evaluation.
Conclusion
Regular kidney function tests are a vital part of safely using SGLT2 inhibitors. They help detect potential problems early, ensuring that patients can continue to benefit from these medications while maintaining kidney health. Always follow your healthcare provider’s recommendations for testing and monitoring.